Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody‐derivatized polyethylenimines (PEI)

The ideal non‐viral vector should be cell‐type directed and form complexes with DNA that are physically stable, small and electrically neutral.

[1]  A. Kabanov,et al.  Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. , 1998, Bioconjugate chemistry.

[2]  K Mechtler,et al.  The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells , 1998, Gene Therapy.

[3]  G. Merlo,et al.  Polyethylenimine-based intravenous delivery of transgenes to mouse lung , 1998, Gene Therapy.

[4]  J. Behr,et al.  Convenient polymer-supported synthetic route to heterobifunctional polyethylene glycols. , 1998, Bioconjugate chemistry.

[5]  K. Ulbrich,et al.  Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. , 1998, Biochimica et biophysica acta.

[6]  G. Levi,et al.  Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system , 1998, Gene Therapy.

[7]  C. Steer,et al.  In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides , 1998, Nature Medicine.

[8]  J. Behr,et al.  In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. , 1997, Bioconjugate chemistry.

[9]  K. Kataoka,et al.  Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. , 1997, Bioconjugate chemistry.

[10]  A. Maruyama,et al.  Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid). , 1997, Bioconjugate chemistry.

[11]  I. Verma,et al.  Gene therapy - promises, problems and prospects , 1997, Nature.

[12]  B. Demeneix,et al.  Adenovirus enhancement of polyethylenimine-mediated transfer of regulated genes in differentiated cells , 1997, Gene Therapy.

[13]  F. Szoka,et al.  The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes , 1997, Gene Therapy.

[14]  L. Monaco,et al.  Nanoscopic structure of DNA condensed for gene delivery. , 1997, Nucleic acids research.

[15]  M. Buchberger,et al.  Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery , 1997, Gene Therapy.

[16]  P. Cullis,et al.  Nomenclature for synthetic gene delivery systems. , 1997, Human gene therapy.

[17]  V. Combaret,et al.  In vitro targeting and specific transfection of human neuroblastoma cells by chCE7 antibody-mediated gene transfer , 1997, Gene Therapy.

[18]  K. Rice,et al.  Peptide-mediated gene delivery: influence of peptide structure on gene expression. , 1997, Bioconjugate chemistry.

[19]  D. Papahadjopoulos,et al.  Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene delivery , 1997, FEBS letters.

[20]  J. Behr,et al.  Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. , 1996, Gene therapy.

[21]  K. Ulbrich,et al.  Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. , 1996, Human gene therapy.

[22]  E. Brambilla,et al.  An electron microscopy study into the mechanism of gene transfer with lipopolyamines. , 1996, Gene therapy.

[23]  K. Mislick,et al.  Evidence for the role of proteoglycans in cation-mediated gene transfer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Benoist,et al.  A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. , 1996, Human gene therapy.

[25]  K. Mechtler,et al.  Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. , 1996, Human gene therapy.

[26]  Ronald G. Crystal,et al.  Transfer of Genes to Humans: Early Lessons and Obstacles to Success , 1995, Science.

[27]  Joseph Zabner,et al.  Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid (*) , 1995, The Journal of Biological Chemistry.

[28]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Monsigny,et al.  Glycosylated polylysine/DNA complexes: gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size. , 1995, Bioconjugate chemistry.

[30]  K. Mechtler,et al.  Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. , 1995, Human gene therapy.

[31]  D. Papahadjopoulos,et al.  Liposomes revisited , 1995, Science.

[32]  S. Zalipsky.  Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. , 1995, Bioconjugate chemistry.

[33]  A A Bogdanov,et al.  Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. , 1994, Biochimica et biophysica acta.

[34]  H. Paik,et al.  Ionization of Poly(ethylenimine) and Poly(allylamine) at Various pH′s , 1994 .

[35]  K. Mechtler,et al.  Carbohydrate receptor-mediated gene transfer to human T leukaemic cells. , 1994, Glycobiology.

[36]  T. Allen.  Long-circulating (sterically stabilized) liposomes for targeted drug delivery. , 1994, Trends in pharmacological sciences.

[37]  G Blume,et al.  Molecular mechanism of the lipid vesicle longevity in vivo. , 1993, Biochimica et biophysica acta.

[38]  K. Zatloukal,et al.  Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. , 1992, Bioconjugate chemistry.

[39]  V. Torchilin,et al.  Use of N-terminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells. , 1992, Bioconjugate chemistry.

[40]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[42]  V. Torchilin,et al.  Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo , 1991, FEBS letters.

[43]  M. Cotten,et al.  Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  V. Torchilin,et al.  Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.

[45]  G Gregoriadis,et al.  Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. , 1991, Biochimica et biophysica acta.

[46]  S. Gillies,et al.  Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody. , 1990, Journal of immunology.

[47]  M. Monsigny,et al.  Colorimetric determination of neutral sugars by a resorcinol sulfuric acid micromethod. , 1988, Analytical biochemistry.

[48]  D. Beck,et al.  In vitro antigenic modulation of human neuroblastoma cells induced by ifn‐γ, retinoic acid and dibutyryl cyclic amp , 1987, International journal of cancer.

[49]  K. Mujoo,et al.  Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. , 1987, Cancer research.

[50]  R. Townsend,et al.  Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. , 1983, The Journal of biological chemistry.

[51]  J Carlsson,et al.  Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. , 1978, The Biochemical journal.

[52]  S. Snyder,et al.  An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. , 1975, Analytical biochemistry.

[53]  J. Behr,et al.  Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway , 1999, Gene Therapy.

[54]  J. Behr,et al.  Polyethylenimines: A Family of Potent Polymers for Nucleic Acid Delivery , 1999 .

[55]  Jp Behr.  L'éponge à protons : un moyen d'entrer dans une cellule auquel les virus n'ont pas pensé , 1996 .

[56]  D. Curiel,et al.  Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. , 1996, Cancer gene therapy.

[57]  J. Rémy.  Synthese et utilisation in vitro de nouveaux vecteurs de transfert de genes , 1994 .

[58]  G. Ashwell,et al.  SECTION 2 – The Hepatic Receptor for Asialoglycoproteins , 1982 .